CRO Data Quality: Why Sponsor Datasets Slow MIDD
CRO data quality decides how fast MIDD models reach regulators. See what a pharmacometric CRO survey reveals about sponsor data, costs, and AI-led fixes.
Could Biological Ageing Be the Next Big Shift in Drug Discovery?
“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."
Synthetic Genetic Codes Move Closer to Programmable Biology
Synthetic genetic codes are moving closer to programmable biology as automated cell-free systems enable faster testing of new protein chemistries in R&D.
Could Roche’s Molecular Glue Deal Signal a New Drug Discovery Race?
Drug discovery in molecular glues gains momentum as Roche partners with Chinese company, Defand Therapeutics.
How Sensor-Enhanced Patient Data Completes the Story of the Trial
How much can clinical trials miss when researchers rely solely on patient-reported outcomes? Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, joins Trisha Pillay to discuss how wearable sensors complement electronic clinical outcome assessments (eCOA).
Integrated Pharma Operations and Supply Chain Management
Pharma operations and supply chain management are converging with forecasting, manufacturing, resilience, and digitalisation of Technical Operations.